Hilary Baldwin, M.D., comments on the impact of the recent approval of clascoterone cream 1% in the topical acne armamentarium of patients suffering from acne.
Hilary Baldwin, MD
Advertisement
Hilary Baldwin, MD, is the medical director of the Acne Treatment and Research Center in Brooklyn, New York.
Articles by Hilary Baldwin, MD
Advertisement
Advertisement
Advertisement
Trending on Dermatology Times
1
The New Economics of Dermatology Claims: Understanding and Responding to Rising Denials
2
Visible Vitiligo Linked to Significant Stigma and Behavioral Adaptations, According to Global Survey
3
Striking the Balance with JAK Inhibitors in Atopic Dermatitis Management
4
Vitiligo-Like Depigmentation Reported in NHEJ1-Related Radiosensitive SCID
5